VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market
Holding VYNE?
Track your performance easily

VYNE Therapeutics (VYNE) Financial Statements

1,810 Followers

VYNE Therapeutics Financial Overview

VYNE Therapeutics's market cap is currently ―. The company's EPS TTM is $-5.424; its P/E ratio is -0.39; VYNE Therapeutics is scheduled to report earnings on August 9, 2024, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 98.00K$ 76.00K$ 114.00K$ 135.00K$ 99.00K
Gross Profit$ 100.00K$ 52.00K$ 114.00K$ 135.00K$ 99.00K
EBIT$ -7.38M$ -6.83M$ -6.07M$ -10.04M$ -5.61M
EBITDA$ -7.38M$ -6.83M$ -6.07M$ -10.04M$ -5.61M
Net Income Common Stockholders$ -6.25M$ -6.19M$ -6.58M$ -10.04M$ -5.61M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 85.95M$ 93.25M$ 15.45M$ 20.63M$ 30.28M
Total Assets$ 91.68M$ 97.69M$ 19.27M$ 24.96M$ 35.26M
Total Debt$ 180.00K$ 214.00K$ 0.00$ 0.00$ 0.00
Net Debt$ -85.77M$ -93.04M$ -15.45M$ -20.63M$ -30.28M
Total Liabilities$ 8.29M$ 8.95M$ 7.76M$ 7.69M$ 8.82M
Stockholders Equity$ 83.36M$ 88.73M$ 11.51M$ 17.27M$ 26.44M
Cash Flow-
Free Cash Flow$ -8.00M$ -5.14M$ -5.10M$ -9.60M$ -5.39M
Operating Cash Flow$ -8.00M$ -5.14M$ -5.10M$ -9.60M$ -5.39M
Investing Cash Flow$ -3.57M$ -62.35M--$ 5.00M
Financing Cash Flow$ -4.00K$ 82.66M$ -47.00K$ -5.00K$ -217.00K
Currency in USD

VYNE Therapeutics Earnings and Revenue History

VYNE Therapeutics Debt to Assets

VYNE Therapeutics Cash Flow

VYNE Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis